Key Financial Inc Has $186,000 Stock Position in Zoetis Inc. (NYSE:ZTS)

Key Financial Inc boosted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 12.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 953 shares of the company’s stock after purchasing an additional 105 shares during the period. Key Financial Inc’s holdings in Zoetis were worth $186,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. F M Investments LLC bought a new stake in shares of Zoetis in the 3rd quarter valued at about $288,000. Chicago Partners Investment Group LLC boosted its stake in shares of Zoetis by 11.8% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 2,518 shares of the company’s stock worth $476,000 after acquiring an additional 265 shares during the period. Chapman Investment Management LLC increased its holdings in shares of Zoetis by 1.1% during the 3rd quarter. Chapman Investment Management LLC now owns 21,210 shares of the company’s stock worth $4,144,000 after acquiring an additional 235 shares during the last quarter. Americana Partners LLC raised its stake in Zoetis by 62.7% in the 3rd quarter. Americana Partners LLC now owns 7,815 shares of the company’s stock valued at $1,527,000 after acquiring an additional 3,013 shares during the period. Finally, Shepherd Financial Partners LLC lifted its holdings in Zoetis by 3.1% during the 3rd quarter. Shepherd Financial Partners LLC now owns 8,555 shares of the company’s stock valued at $1,672,000 after purchasing an additional 258 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently weighed in on ZTS shares. Argus raised shares of Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. JPMorgan Chase & Co. raised their price objective on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Stifel Nicolaus upped their target price on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Wednesday, September 18th. Piper Sandler lifted their price target on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. Finally, BTIG Research upped their price objective on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a report on Monday, August 12th. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Zoetis presently has a consensus rating of “Buy” and a consensus price target of $221.44.

Zoetis Price Performance

ZTS stock traded up $3.17 during mid-day trading on Friday, hitting $181.95. The stock had a trading volume of 2,838,633 shares, compared to its average volume of 1,795,404. The firm has a fifty day simple moving average of $188.97 and a 200 day simple moving average of $178.51. The firm has a market capitalization of $82.43 billion, a P/E ratio of 35.61, a P/E/G ratio of 2.78 and a beta of 0.90. The company has a current ratio of 3.45, a quick ratio of 2.09 and a debt-to-equity ratio of 1.32. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.49 by $0.07. The business had revenue of $2.36 billion for the quarter, compared to analysts’ expectations of $2.31 billion. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The firm’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same period last year, the firm posted $1.41 earnings per share. As a group, research analysts forecast that Zoetis Inc. will post 5.83 EPS for the current year.

Zoetis Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be paid a $0.432 dividend. This represents a $1.73 annualized dividend and a yield of 0.95%. The ex-dividend date of this dividend is Thursday, October 31st. Zoetis’s dividend payout ratio (DPR) is presently 33.66%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.